Conjunctival Melanoma Targeted Therapy: MAPK and PI3K/mTOR Pathways InhibitionIkram El Zaoui(University of Lausanne), Alexandre Moulin(Hôpital Ophtalmique Jules-Gonin)Investigative Ophthalmology & Visual ScienceJune 27, 201910.1167/iovs.18-26508Cited by 32SaveCiteExport RISWatch citationsRelated PapersOrbital exenteration and conjunctival melanoma: a 14-year study at the Jules Gonin Eye Hospital|Eye|2020|19